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Epidemiological studies and case reports show that even a
relatively minor degree of maternal hypothyroxinemia dur-
ing the first half of gestation is potentially dangerous for op-
timal fetal neurodevelopment. Our experimental approach
was designed to result in a mild and transient period of ma-
ternal hypothyroxinemia at the beginning of corticogenesis.
Normal rat dams received the goitrogen 2-mercapto-1-methyl-
imidazole for only 3 d, from embryonic d 12 (E12) to E15.
Maternal thyroid hormones decreased transiently to 70% of
normal serum values, without clinical signs of hypothyroid-
ism. Dams were injected daily with 5-bromo-2-deoxyuridine
(BrdU) during 3 d, from E14–E16 or E17–E19. Their pups were
tested for audiogenic seizure susceptibility 39 d after birth
(P39) and killed at P40. Cells that had incorporated BrdU were
identified by immunocytochemistry, and quantified: numer-
ous heterotopic cells were found, whether labeled at E14–E16
or E17–E19, that were identified as neurons. The cytoarchi-
tecture and the radial distribution of BrdU-labeled neurons
was significantly affected in the somatosensory cortex and
hippocampus of 83% of the pups. The radial distribution of
-aminobutyric acidergic neurons was, however, normal. The
infusion of dams with T4 between E13 and E15 avoided these
alterations, which were not prevented when the T4 infusion
was delayed to E15–E18. In total, 52% of the pups born to the
goitrogen-treated dams responded to an acoustic stimulus
with wild runs, followed in some by seizures. When extrapo-
lated to man, these results stress the need for prevention of
hypothyroxinemia before midpregnancy, however moderate,
and whichever the underlying cause. (Endocrinology 145:
4037–4047, 2004)
NEOCORTICOGENESIS IS AN early process in the de-velopment of the central nervous system (CNS) that
begins by the fifth week of gestation in humans (1, 2) and by
embryonic d 11 (E11) in rats (3). During this process, radially
and tangentially migrating neurons are described (4–6),
which give rise to glutamatergic (excitatory) and to -
aminobutyric acidergic (GABAergic; inhibitory) neurons, re-
spectively. The maternal thyroid is then the only source of T4
and T3 for the brain of the fetus because its thyroid gland does
not start contributing to fetal requirements until midgesta-
tion in man, and E17.5–E18 in rats. Therefore, the amount of
maternal T4 that the fetus receives early in pregnancy will
determine thyroid hormone action in its brain because it
depends on maternal T4 for its intracellular supply of the
active form of the hormone, T3. Maternal hypothyroxinemia
during this period of brain development may result in poor
fetal neurodevelopment, a possibility that is strongly sup-
ported by an increasing number of epidemiological studies
and case reports, which have been recently reviewed (7–10).
The term hypothyroxinemia indicates that, whether or not
TSH is increased above normal values, as in primary hypo-
thyroidism, T4 or free T4 (FT4) is low compared with values
usually found at the same stage of pregnancy in normal
women with an adequate iodine intake (7, 8).
The most severe CNS brain damage, that of the neurolog-
ical cretin, is the result of early and profound maternal hy-
pothyroxinemia, caused by severe iodine deficiency (ID).
This condition impairs the adequate production and secre-
tion of T4 by the maternal thyroid. As discussed more ex-
tensively elsewhere (7, 11), the degree of the neurological
damage is related to the severity of the maternal hypothy-
roxinemia and not to her circulating T3 or TSH levels, which
are normal. Even more important, as a public health problem,
is that in ID areas the mental development of the noncretin
population is also affected. Both neurological cretinism and
the mental impairment of the general population can only be
prevented before midgestation.
We have recently described what we believe is the first
direct experimental evidence of a potentially irreversible
damage to the fetal brain caused by early maternal hypo-
thyroxinemia, without hypothyroidism (11). Pups born to
severely iodine-deficient dams showed alterations in the cy-
toarchitecture of the somatosensory cortex and hippocam-
pus, and in the radial neuronal migration into the neocortex,
which had been caused by events taking place before onset
of active fetal thyroid secretion. Such alterations may well be
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causally related to the neurodevelopmental handicaps de-
scribed in neurological cretins and the general population of
areas with severe ID. The study, however, did not directly
address some of the questions raised by an increasing num-
ber of reports, which strongly suggest that milder degrees of
maternal hypothyroxinemia, caused by moderate ID, or by
mild thyroid failure from other causes, increase the risk of
bearing children with an intelligence quotient (IQ) of 85 or
less, with a frequency that may be 150–200 times that of
children born with congenital hypothyroidism (7).
Some of these questions could not be answered previously
because of the experimental design that had been used (11).
The dams were severely hypothyroxinemic before and
throughout pregnancy and lactation, and therefore we could
not define: 1) a window of special sensitivity of the devel-
oping brain to the decrease in maternal T4; 2) the degree of
maternal hypothyroxinemia required to observe alterations
of neuronal migration in the progeny; 3) the timing after
which normalization of the maternal hypothyroxinemia
might no longer prevent fetal CNS damage; and 4) whether
the alteration of the migratory phase of cells labeled with
5-bromo-2-deoxyuridine (BrdU) at E17–E19, was a conse-
quence of derangement of the previous phase. It also ap-
peared interesting to determine whether, or not, the tangen-
tial neuronal migration was also affected, for which different
subtypes of GABAergic neurons were studied.
To answer this type of question, we have here restricted
both the degree and the duration of the maternal thyroid
dysfunction, by treating normal dams with a goitrogen for
only 3 d at the beginning of neocorticogenesis.
Materials and Methods
Animals and treatments
Wistar rats were housed in temperature-controlled (22–24 C) animal
quarters, with automatic light and darkness cycles of 14 and 10 h, under
veterinary control according to European Community guidelines and
after approval by the Ethics Committee of our Institutions.
Young adult females, weighing approximately 200 g, were mated
with normal males on E0. The main experimental series are described
in Fig. 1, with the number of animals studied in each group for the
different endpoints1 and consisted of: one group of normal rats and three
groups of dams that drank 0.02% 2-mercapto-1-methylimidazole (me-
thimazole, MMI) from E12–E15. One group received MMI treatment
alone (3dMMI12), and the other two groups were infused with T4, again
for 3 d, from E13–E16 (3dMMI12  T4–13) and from E15–E18 (3dMMI12
 T4–15); the subscripts indicate the day of onset of treatments (Fig. 1).
Onset of T4 infusion was delayed for 1 d after onset of MMI, considering
that its effects on circulating hormone levels were likely to be more rapid
than those of the oral administration of MMI. A pilot experiment (12)
was carried out infusing for 3 d a dose of 2.4g T4/100 g body weight/d
that is adequate to maintain euthyroidism of thyroidectomized adult
rats (13). This dose increased circulating T4 and T3 about 4-fold. Thus,
for the present study we infused 0.6 g T4/100 g body weightd. The
solution was prepared as previously described (14) and infused using
osmotic minipumps (ALZET, model 2001, Alza Corp., Palo Alto, CA),
placed under the dorsal skin (13).
The pregnant rats of all the above groups were injected ip for 3 d with
BrdU, 20 mg/kg body weightd, dissolved in physiological saline. Half
of each group of dams was injected on E14, E15, and E16 (3dBrdU14
subgroups), and the other half at E17, E18, and E19 (3dBrdU17 sub-
groups). There was no 3dBrdU17 subgroup of 3d-MMI12  T4–15 dams
(Fig. 1; see footnote1).
Blood (0.5 ml) was obtained under slight ether anesthesia from the
jugular vein from dams of the four main experimental groups on the
mornings of E15 and E19. The plasma was spun off and kept at 20 C,
for the determination of T4, T3, and TSH concentrations.
In all cases, both onset and withdrawal of treatments were carried out
between 0800 and 1000 h.
At 2–3 d of postnatal age (P2–P3) each litter was culled to eight pups.
At P39, pups from the four groups were tested for their audiogenic
seizure susceptibility, and at P40 all pups were weighed, anesthetized,
bled, and perfused with 50 ml saline followed by 200 ml 4% parafor-
maldehyde and 0.1 m sucrose in 10 mm phosphate buffer (PB, pH
7.3–7.4), containing 0.002% CaCl2. The brains were postfixed by immer-
sion in PB at room temperature for 4 h, and stored at 4 C in PB containing
0.1 m sucrose.
Immunohistochemistry
The brain was coronally sectioned using a Vibratome PELCO 101 (Ted
Pella Inc., Redding, CA) in eight parallel series of 100 m-thick sections.
Sections containing the primary somatosensory cortex (taken at 2.0 to
4.0 mm from bregma) and the mediocaudal portion of the hippocam-
pal formation and the primary auditory cortex (both, at3.8 to4.3 mm
from bregma) were collected in PB saline. One series was immuno-
stained with anti-BrdU monoclonal antibody (mAb; 1:40), biotinylated
horse antimouse antibody (Ab; 1:150), Vectastain ABC kit (Vector, Bur-
lingame, CA; 1:200), and 0.05% 3,3diaminobenzidine (DAB) (15). These
dilutions were the same whenever these four reagents were used. An
adjacent series was stained with cresyl violet. Six series were double
1 The number of animals used per group for the different endpoints
in normal (a), 3dMMI12 (b), 3dMMI12  T4–13 (c) and 3dMMI12  T4–15
(d) groups was as follows: Number of dams for sampling for hormone
determinations of pregnant dams at E15: a (n  5); b (n  7); c (n  4);
and d (n 8). Number of dams for hormone determination at E19: a (n
9); b, (n  8); c (n  4); and d (n  8). Number of pups for hormone
determinations at P40: a (n  13); b (n  15); c (n  11); and d (n  15).
Number of pups per litter used for audiogenic seizure susceptibility
studies: a, 46 pups of nine litters (46/9); b, 38/5; c, 32/4; and d, 55/10.
The number of dams used for morphological studies was: a (n  6); b
(n  12); c (n  12); and d (n  4). Number of pups per litter used for
quantitative immunohistochemistry, except for 3dBrdU17 subgroups,
were: a, eight pups of two litters (8/2); b, 11/3; c, 11/3; d, 10/3. Number
of pups per litter used for quantitative analysis of 3dBrdU17 subgroups,
were: a, seven pups of two litters (7/2); b, 9/3; c, 9/3.
FIG. 1. Shows the four main groups of rats and the different treat-
ments applied. The BrdU14 and BrdU17 subgroups are indicated by
white and gray bars, respectively. The length of MMI and T4 treat-
ments are indicated by lined bars. The day of each BrdU injection is
indicated by a black square. Behavioral tests were performed at P39,
and the rats were perfused at P40.
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immunostained. Two of them were double immunostained for fluores-
cence, starting with sheep anti-BrdU Ab (10 g/ml), biotinylated rabbit
antisheep Ab (5 g/ml), and NeutrAvidin (Molecular Probes Europe,
Leiden, The Netherlands), Rhodamine Red (Molecular Probes Europe)
conjugate (1 g/ml). One of these two series was then immunostained
with antineuronal nuclei (NeuN) mAb (1:400), a marker for neurons; the
other with anti-2,3-cyclic nucleotide 3 phospodiesterase (CNP) mAb
(5 g/ml), a marker for oligodendrocytes. They were then incubated
with biotinylated horse antimouse Ab and Avidin (Molecular Probes
Europe), BODIPY FL (Molecular Probes Europe) conjugate (1 g/ml).
The remaining four series were immunostained for conventional light
microscopy with markers of different subtypes of GABAergic neurons
(16–19). In two series; the sections were first processed with rabbit
anticalretinin Ab (1:2000) or rabbit antineuronal nitric oxide synthase
(nNOS) Ab (1:100), which was followed with biotinylated goat antirabbit
Ab (1:150), ABC kit, and DAB. These sections were then double-immu-
nostained with anti-BrdU mAb, followed with biotinylated horse anti-
mouse Ab, ABC kit and DAB, intensified with 0.1% ammonium nickel
sulfate (20). The remaining two series were first processed with sheep
anti-BrdU Ab (10 g/ml), followed with biotinylated rabbit antisheep
Ab (5 g/ml), ABC kit and DAB, intensified with 0.1% ammonium
nickel sulfate (20). One series was immunostained with antiparvalbumin
mAb (1:1000), the other, with anticalbindin D-28K mAb (1:2000). They
were then immunostained with biotinylated horse antimouse Ab, ABC
kit and DAB. Immunostained sections were mounted on gelatinized
slides, air dried during 24 h, dehydrated in ethanol, cleared in xylol, and
coverslipped.
For quantitative analysis, we have studied five to 11 pups of two to
three litters of dams from the subgroups of the four main experimental
groups,1 and also from 3dMMI10 and 3dMMI11 dams (see Results). In
each instance, cells immunoreactive to BrdU, parvalbumin, calbindin
D-28K, calretinin, and nNOS were counted in a total of nine to 12 probes
in the primary somatosensory cortex (one to two probes per pup); the
mean values corresponding to each pup were later used for statistical
evaluation of the results. Probes 600-m wide were placed over the
primary somatosensory cortex and spanned from layer I to the subcor-
tical white matter, as previously detailed (11). In all cases, the borders
between layers and strata were placed at the same relative depth, mea-
sured from adjacent cresyl violet-stained sections. The relative frequen-
cies of immunoreactive (ir) cells in each layer were averaged across
probes and animals. We plotted only BrdU-ir cells that showed intensely
and homogeneously labeled nuclei, or diffusely labeled nuclei of lesser
intensity, but with clumped chromatin. These cells have entered the last
S-phase of their cell cycle during uptake of the injected BrdU and cor-
respond to types 1 and 2, respectively, of Takahashi et al. (21).
Drugs and reagents
BrdU was from Roche Molecular Biochemicals Espan˜a (Barcelona,
Spain). T4, MMI, DAB, and cresyl violet were obtained from Sigma-
Aldrich (St. Louis, MO). Anti-BrdU mAb was from Amersham Phar-
macia Biotech Ltd. (Little Chalfont, Buckinghamshire, UK). Sheep anti-
BrdU and biotinylated rabbit antisheep Abs were from Abcam Ltd.
(Cambridge, UK). Horse antimouse and goat antirabbit biotinylated
Abs, Anti-NeuN, and anti-CNP mAb were from Chemicon International
Inc. (Temecula, CA). Antiparvalbumin and anticalbindin D-28K mAbs
and rabbit anticalretinin Ab were from Swant (Bellinzona, Switzerland).
Rabbit anti-nNOS Ab was obtained from Zymed Laboratories Inc. (San
Francisco, CA).
Determination of serum T3, T4, and TSH
Their concentrations were determined by very sensitive and highly
specific RIAs for T4 and T3 (22) and TSH (23). TSH values are expressed
as weight equivalents of the National Institute of Diabetes and Digestive
and Kidney Diseases rat TSH-RP-3 reference preparation.
Audiogenic seizure susceptibility
At P39, pups were exposed to the electric doorbell used by van
Middlesworth (24, 25) to study audiogenic seizure susceptibility of rat
pups born from iodine-deficient or goitrogen-treated dams. Rats were
individually placed in a plastic cage. The electric bell was placed 20 cm
from the bottom of the cage, so that the intensity of the sound reaching
the rat was 95–100 dB. Once the bell was switched on, stimulation was
maintained for 90 sec, unless the animal responded with a tonic-clonic
seizure, when rapidly interrupted. The animals were observed for the
onset of wild runs, or wild runs followed by seizures, and the onset of
each type of reaction was timed. Rats were returned to their initial cages
until they were killed for the immunohistochemical studies. The dams
used for this part of the study were from the same strain previously used
to assess audiogenic seizure susceptibility in pups from iodine-deficient
dams (14).
Statistical analysis
Plots and counts of ir cells were obtained using the Neurograph
system (Microptic, Barcelona, Spain). The Systat statistical software (Sys-
tat Inc., Evanston, IL) was used for two-way ANOVAs of cell density,
factors being layers and experimental groups. Significant layers-groups
interactions (P 0.001) were found in the primary somatosensory cortex
the primary somatosensory cortex both for the 3dBrdU14 and 3dBrdU17
subgroups. One-way ANOVAs of ir-cell densities were then used to
identify layers that were affected by the experimental condition, fol-
lowed by Tukey’s test to identify significant differences (P  0.05)
between means.
The SPSS statistical package (SPSS Inc., Chicago, IL) was used for
detection of differences between concentrations of hormones, number of
pups/litter, and body weight, with one-way ANOVA and the protected
least significant difference test for multiple comparisons, after validation
of the homogeneity of variances by the Bartlett-Box F test; for the au-
diogenic seizure susceptibility variables using the Mann-Whitney non-
parametric test for frequencies with which the pups responded with
wild runs, or wild runs followed by seizures. The Kaplan-Meier survival
analysis was applied to the timing of onset of wild runs or seizures. The
test calculates the percentage of pups that survive the 90-sec acoustic
challenge without a response.
Results
Effects of different treatments on thyroid function
At E15 (Table 1), maternal plasma T4 concentration of the
3dMMI12 and 3dMMI12 T4–15 dams decreased significantly
(P  0.05) to approximately 70% of values of normal dams.
On the contrary, the plasma T4 of the 3dMMI12 T4–13 dams
was higher than that of 3dMMI12 and normal dams. Plasma
T3 changed similarly, decreasing in both 3dMMI12 and
3dMMI12  T4–15 dams; T3 in 3dMMI12  T4–13 dams was
higher than that of 3dMMI12 dams and not different from
normal. Although mean plasma TSH values were higher in
3dMMI12 and 3dMMI12  T4–15 dams compared with those
of the control group differences among these three groups
were not statistically significant. This lack of a rapid and
commensurate increase of circulating TSH in the 3dMMI12
and 3dMMI12  T4–13 dams, despite the decrease in circu-
lating T4 and T3, supports the concept of hypothyroxinemia
(7), namely, that low T4 and T3 concentrations are not nec-
essarily accompanied by an increased TSH. TSH was lower
in the 3dMMI12  T4–13 dams than in dams from the other
three groups.
At E19 (Table 1), plasma T4 values of the 3dMMI12 and
3dMMI12 T4–13 dams were no longer different from that of
normal ones, whereas the mean value was higher in the
3dMMI12  T4–15 dams, although the difference was not
statistically significant. There were no differences among
groups in plasma T3. Plasma TSH was the same as that of
normal dams for all groups except for the lower value of the
3dMMI12  T4–15 dams.
No differences were found among experimental groups at
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P0 in the number of pups born to the dams (9.4  1.03), or
at P40 in their body weight (131.9 0.90 g), plasma T4 (31.2
1.0 ng/ml) and T3 (0.97  0.02 ng/ml), or TSH (0.48  0.02
ng/ml).
Distribution of cells
The radial distribution of BrdU-ir nuclei in the primary
somatosensory cortex was abnormal in many pups of the
3dBrdU14 subgroups of 3dMMI12 and 3dMMI12  T4–15
dams, with heterotopic BrdU-ir cells at locations different
from those corresponding to their birth date (Fig. 2). In these
pups, the percentage of BrdU-ir cells decreased in layers IV
and V, and increased in layer VI and subcortical white matter
(see P values in Fig. 2), whereas no differences were found
between 3dMMI12  T4–13 and normal pups. These alter-
ations in radial migration, revealed by the presence of het-
erotopic neurons in the subcortical white matter, were milder
in two of 12 of the 3dMMI12 and one of nine of the 3dMMI12
 T4–15 pups. They were never observed in the pups from
normal dams. Heterotopic BrdU-ir cells were also found in
the subcortical white matter of the auditory cortex (not
shown). On visual inspection, their number appeared similar
to that found in the primary somatosensory cortex.
Alterations in the radial distribution of BrdU-ir cells from
the 3dBrdU17 subgroups of normal, 3dMMI12 and 3dMMI12
 T4–13 pups were also detected (Fig. 3). Compared with
pups from the normal dams, the proportion of BrdU-ir cells
in pups from the 3dMMI12 dams decreased in layers II–III
and IV, and increased in layers V, VI, and in the subcortical
white matter. Such alterations were not observed in pups
born to 3dMMI12  T4–13 mothers.
Two additional groups of two dams each were also treated
for 3 d with MMI, but starting at E10 and E11, and injected
with BrdU as described. All pups from these 3dMMI10 and
3dMMI11 dams showed a radial distribution of BrdU-ir cells
comparable to that illustrated in Figs. 1 and 2 for 3dMMI12
pups.
In contrast with the radial distribution of the BrdU-ir cells,
the radial distribution of neurons immunoreactive to parv-
albumin, calbindin D-28K, calretinin, and nNOS was similar
in all groups to that of pups from normal dams (Fig. 2). Two
types of calbindin D-28K-ir neurons (heavily and lightly
FIG. 2. Plots of cells from normal (A), 3dMMI12 
T4–13 (B), 3dMMI12  T4–15 (C), and 3dMMI12 (D)
pups at P40, that are ir to BrdU (BrdU-ir;
3dBrdU14 subgroups), to parvalbumin (PV-ir), to
calretinin (CR-ir), to nNOS (nNOS-ir) and heavily
ir to calbindin D-28K (CB-ir). Histograms (right
side of the plots) show results of their quantifica-
tion in different cortical layers of the primary so-
matosensory cortex. The borders between layers
are indicated by horizontal lines. Asterisks indicate
a statistically significant difference between pups
(normal and 3dMMI12T4–13 vs. 3dMMI12T4–15
and 3dMMI12), as revealed by the F and P values.
The degrees of freedom were 3, 36. NS, Not statis-
tically significant differences. Same magnification
for PV-ir, CR-ir, nNOS, and CB-ir plots.
TABLE 1. Circulating T4, T3, and TSH in dams from the experimental groups at E15 and E19
Pregnant dams at E15 Pregnant dams at E19
T4 T3 TSH T4 T3 TSH
Normal 15.90  1.89 0.37  0.03 0.91  0.45 13.40  1.19 0.38  0.04 0.47  0.08
3dMMI12  T4–13 21.00  1.27
a 0.40  0.02 0.53  0.11 9.50  0.77 0.27  0.03 0.69  0.13
3dMMI12  T4–15 10.50  0.02
a,b 0.22  0.02a,b 1.00  0.03 16.50  1.43 0.32  0.03 0.32  0.03
3dMMI12 11.60  0.67
a,b 0.29  0.02a,b 1.44  0.38b 12.70  0.95 0.35  0.05 0.63  0.14
Data represent the mean value  SEM. The TSH values are expressed as weight equivalents of the NIDDK-Rat TSH-RP-3 reference
preparation. All units shown are nanograms per milliliter.
a A statistically significant difference compared with normal rats.
b A statistically significant difference compared with 3dMMI12  T4–13 rats.
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labeled) were observed according to the intensity of the im-
munostaining. Heavily labeled calbindin D-28K-ir neurons
showed a morphology corresponding to local circuit neu-
rons, whereas most of the lightly stained calbindin D-28K-ir
neurons resembled pyramidal cells, mostly located in layers
II-III. In the four main experimental groups, the parvalbu-
min-ir and calbindin D-28K-ir neurons were mostly found in
cortical layers II–III to VI. The radial distribution of parval-
bumin-ir neurons was very uniform with a moderate high
density in layer V (Fig. 2). The proportion of heavily labeled
calbindin D-28K-ir neurons was similar in layers II–III, V,
and VI with a decrease in layer IV (Fig. 2). Calretinin- and
nNOS-ir neurons were also found in layers II–III to VI, with
the proportion being lower in layer IV. In contrast to parv-
albumin- and heavily labeled calbindin D-28K-ir neurons, a
small but significant number of calretinin- and nNOS-ir neu-
rons were observed in layer I and in the subcortical white
matter (Fig. 2).
Cytoarchitectonic changes
In addition to an abnormal migration of BrdU-ir cells, we
also observed changes in cresyl violet-stained coronal sec-
tions obtained from pups of the 3dMMI12 and 3dMMI12 
T4–15 dams, both as regards the cytoarchitecture of the barrel
cortex of the primary somatosensory cortex and of the hip-
pocampus, whereas these features were normal in the
3dMMI12T4–13 pups (Fig. 4, A and B). Although not shown,
changes observed in pups from the 3dMMI10 and 3dMMI11
dams were again comparable to those from the 3dMMI12
dams. The major features in the normal pups were typical
barrels in layer IV, and easily distinguishable borders be-
tween layers. In contrast, these features are less prominent in
the progeny of 3dMMI12 and 3dMMI12  T4–15 dams (Fig. 4,
C and D). These changes were not seen in the 3dMMI12 
T4–13 pups (Fig. 4B). No statistically significant differences
were found in the thickness of the neocortex among the four
groups (on average, 1740 67 m). Again, changes in all the
pups from the 3dMMI10 and 3dMMI11 dams (not shown)
were comparable to those from the 3dMMI12 dams.
In the hippocampus, as in the barrel cortex, the gross
cytoarchitecture of 3dMMI12  T4–13 pups (Fig. 4F) was sim-
ilar to that of normal pups (Fig. 4E). In the hippocampal CA1,
the pyramidal cell layer showed clear-cut borders with the
adjacent strata. In contrast, in the hippocampal CA1 of
FIG. 3. Histogram showing the percentages of cells ir to BrdU (BrdU-
ir) in different layers of the primary somatosensory cortex of pups at
P40 from 3dBrdU17 subgroups of normal, 3dMMI12  T4–13 and
3dMMI12 dams. Asterisks indicate a statistically significant difference
between normal (or 3dMMI12T4–13) and 3dMMI12 pups, as revealed
by the F and P values. The degrees of freedom were 2, 22. NS, Not
statistically significant differences.
FIG. 4. Photomicrographs of cresyl violet-
stained coronal sections showing the cytoarchi-
tecture of the barrel cortex of the primary so-
matosensory cortex (A–D) and hippocampus
(E–L) in normal, 3dMMI12  T4–13, 3dMMI12 
T4–15 and 3dMMI12 pups at P40. Borders between
layers (horizontal lines) are clear-cut in normal
(A) and 3dMMI12  T4–13 (B) pups, whereas they
are more blurred in 3dMMI12  T4–15 (C) and
3dMMI12 (D) animals. In layer IV of normal and
3dMMI12  T4–13 pups, barrels (arrows) are nor-
mal and well-defined and demarcated by septae
(arrowheads). In contrast, barrels in layer IV of
3dMMI12  T4–15 and 3dMMI12 pups are not
seen. In I–L panels are enlargements of the insets
outlined in E–H. In the hippocampus, the differ-
ences between groups are not prominent at low
magnification (compare E and F with G and H).
However, at a higher magnification, the border
between strata pyramidale (py) and oriens (or) in
the hippocampal CA1 of normal and 3dMMI12 
T4–13 pups is more clear-cut than in 3dMMI12 
T4–15 and 3dMMI12 pups (compare I and J with K
and L). ra, Stratum radiatum. Same magnifica-
tion for A–D, E–H, and I–L.
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the 3dMMI12 and 3dMMI12T4–15 progeny, the border of the
pyramidal layer with the strata oriens was more blurred (Fig.
4, K–L). The same was observed in pups from the 3dMMI10
and 3dMMI11 dams.
Double-immunolabeling
Double-labeling for BrdU and NeuN showed that all
BrdU-ir cells that were located in heterotopic positions were
neurons, whether found in the subcortical white matter (Fig.
5, C and F) or in the hippocampal stratum oriens and the
hippocampal alveus (Fig. 5, G and H). This result was further
confirmed by the absence of double-labeling for BrdU and
cyclic nucleotide CNP. Double-labeling for CNP was only
occasionally observed (Fig. 5I) for those BrdU-ir cells that
were classified as type 3 after Takahasi et al. (21).
Both in the 3dBrdU14 and 3dBrdU17 subgroups, approxi-
mately 10% of cells that were ir to parvalbumin, calretinin,
calbindin D-28K, and nNOS were also ir to BrdU (see ex-
amples in Fig. 5, J, K, L, and P). However, most of the
heterotopic neurons in the subcortical white matter that
stained with the above markers were BrdU-negative (Fig. 5,
L and O); only in a few cases were cells double-labeled for
BrdU and nNOS observed (Fig. 5, K and M). Other features
of immunostaining with these markers such as size and
shape of the cells were similar to those of normal pups (Fig.
5, N, P, and Q). In 3dMMI12 pups, perisomatic parvalbu-
min-ir terminals were prominent around the soma of pyra-
mids in layers II–III and Va and similar to found in normal
pups (Fig. 5R).
Audiogenic seizure susceptibility
Acoustic stimulation showed that there were significant
differences between the pups born to normal and 3dMMI12
dams in the proportion of pups that responded with wild
runs alone, or with wild runs followed by a seizure (Fig. 6).
The time required by the 3dMMI12 pups to respond (Fig. 6)
was also much shorter. The results obtained in the 3dMMI12
 T4–13 and 3dMMI12 T4–15 pups differed from those of the
FIG. 6. Responses of normal, 3dMMI12  T4–13,
3dMMI12T4–15 and 3dMMI12 and 3dMMI12 pups
to an acoustic stimulus. Panels on the left corre-
spond to the proportion (median with 25th and 75th
percentiles) of pups responding with wild runs and
with wild runs followed by a seizure, respectively.
Panels on the right represent the cumulative fre-
quency of pups from the same groups that respond
with wild runs alone or followed by a seizure, re-
spectively, at the intervals after onset of the stim-
ulus that are shown in the abscissa. a, Indicates a
statistically significant difference compared with
normal, b compared with 3dMMI12  T4–13 and c
compared with 3dMMI12  T4–15 group.
FIG. 5. Confocal photomicrographs showing BrdU and NeuN immunostaining in the primary somatosensory cortex (A–F) and the hippocampal
CA1 (G and H) of normal (A, B, C, and G) and 3dMMI12 (D, E, F, and H) pups at P40 (3dBrdU14 subgroups). Single-labeling to BrdU (A and
D; red) and to NeuN (B and E; green), and double-labeling (C, F, G, and H; yellow) are shown. Note the absence of ir cells in the subcortical
white matter (wm) of the primary somatosensory cortex and alveus (al) of the hippocampal CA1 in normal pups. In the 3dMMI12 pups, all cells
in wm ir to BrdU (D; red) are neurons (F; yellow). Heterotopic neurons (yellow) were also found in the al of 3dMMI12 pups (H). Panel I shows
a BrdU-negative cell ir to CNP that is an oligodendrocyte (arrow; green), as well as nuclei ir to BrdU (red) in layer VI of a 3dMMI12 pup (3dBrdU14
subgroup). Light microscope photomicrographs are shown of the hippocampal CA1 (J) and the primary somatosensory cortex (K–R) of 3dMMI12
pups of the 3dBrdU14 (J–L, O, and Q) and 3dBrdU17 (M, N, P, and R) subgroups. Panels J–N show BrdU and nNOS immunostaining.
Single-labeling to BrdU in wm (dark blue nuclei; arrows in L); single-labeling to nNOS (brown cytoplasm) in wm (arrowheads in L) and in layer
II–III (arrow in N); and double-labeled neurons in wm (K and M) and the stratum oriens of the hippocampal CA1 (J) are shown. Panels O–Q
show BrdU and calretinin immunostaining. Single labeling to BrdU (dark blue nuclei) in the wm (arrows in O); single labeling to calretinin
(brown cytoplasm) in the wm (arrowhead in O) and in layers V (arrow in P) and II–III (arrow in Q); and a double-labeled neuron in layer II–III
(arrowhead in Q) are shown. Panel R shows BrdU and parvalbumin immunostaining. Single parvalbumin-ir neurons in layer V (arrows) and
some perisomatic parvalbumin-ir boutons on the soma of two pyramidal BrdU-ir neurons are indicated (arrowheads). Same magnification for
A–H. Scale bar in I–R, 50 m.
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3dMMI12 group, either in the proportion of animals respond-
ing with wild runs or seizures, in the length of time required
for the response, or in both. The frequency of wild runs and
seizures was similar in pups from both groups of T4-infused
3dMMI12 dams, and was between those observed for the
normal and the 3dMMI12 pups. There was a difference, how-
ever, in the time needed for the wild runs to start: the pups
from the 3dMMI12  T4–15 responded as quickly as the
3dMMI12 pups, whereas those from the 3dMMI12  T4–13
group required a more prolonged stimulation, comparable
with that needed by the few pups from normal dams that
reacted to the acoustic stimulus (Fig. 6).
Discussion
The experimental design
The 3 d of treatment with MMI resulted in a decrease of
maternal circulating T4 and T3, which reverted to normal
after goitrogen withdrawal. The decrease was not only tran-
sient, but also quite moderate when compared with the hy-
pothyroxinemia of the iodine-deficient dams, with undetect-
able T4 levels (2.5 ng/ml), but normal circulating T3 (11).
On the last day of the present 3 d of treatment with MMI,
circulating T4 and T3 had only decreased to about 70% of
normal values. Moreover, there were no appreciable clinical
effects of this treatment, as shown by the normal size of the
litters and the body weight of the pups. It also did not affect
the parameters of thyroid function of the progeny that were
quite normal whichever the treatments of the dam. The MMI-
treated dams will therefore be referred to as being hypothy-
roxinemic (7, 11) because there was no clinical or subclinical
biochemical evidence of hypothyroidism, such as an increase
in circulating TSH.2 Present results also confirm that an
increased TSH should not be systematically used as sole
predictor of primary thyroid function clinically and that
conditions exist where there may be thyroid hormone in-
sufficiency without the expected increase in circulating TSH.
The previous observation (11) that histochemical and cyto-
architectonic alterations were similar in pups from both LID
groups, despite the very different plasma T3 values of their
mothers, is consistent with our present contention that the
decrease to about 70% of circulating T3 in the 3dMMI12 dams
plays a lesser role than their hypothyroxinemia.
The present experimental design also included dams that
were infused with T4 during, or after, the 3-d treatment with
MMI. The decrease of the maternal T4 and T3 levels was
indeed avoided by infusion of T4 during this 3 d of treatment
with MMI, showing that the neurodevelopmental changes
found in their pups are not caused by MMI per se. They also
show that the changes persist if the T4 infusion is delayed.
The relatively mild degree of transient hypothyroxinemia
in pregnant rats, induced with the present design at the
beginning of fetal corticogenesis, was enough to alter the
organization of the neocortex in most of their pups, as re-
vealed by an abnormal migration and cytoarchitecture, and
to result in a functional deficit, as documented by an in-
creased frequency of abnormal responses to an acoustic stim-
ulus. These are, to our knowledge, novel findings. Thus the
present experimental design has contributed to answering
points 1–4 in the introductory section, permitted further
insight into the type of neuronal migration that is affected,
and posed new challenges for further research, especially as
regards possible functional consequences of a relatively mild
degree of transient maternal hypothyroxinemia.
Effects on histogenesis and cytoarchitecture
The alterations of the distribution of BrdU-ir cells among
different layers of the primary somatosensory cortex and the
hippocampal CA1, and the changes in the cytoarchitecture of
these cortical areas found in the progeny of the 3dBrdU14 and
3dBrdU17 subgroups of the 3dMMI12 dams are qualitatively
quite similar to those observed in pups born to iodine-de-
ficient dams that were severely hypothyroxinemic because of
marked, and chronic, ID (11). Another similarity between the
pups of the iodine-deficient and the 3dMMI12 dams is that
the heterotopic BrdU-ir cells found in the subcortical white
matter are neurons. There might, however, be a slight quan-
titative difference: all pups from iodine-deficient dams were
affected, whereas some of the 3dMMI12 pups (15%) were
not. Although there were only two litters per group, all pups
from the 3dMMI10 and 3dMMI11 dams were abnormal, and
this suggests that E12, the only day on MMI common to
3dMMI10, 3dMMI11 and 3dMMI12 dams, might be especially
sensitive to maternal hypothyroxinemia with respect to cy-
toarchitecture and neuronal migration into the neocortex and
hippocampus.
The present evidence that even a mild and transient de-
crease of maternal thyroid hormone insufficiency during
early pregnancy effectively alters early brain development is
in conceptual agreement with the findings described by oth-
ers (27–30), who used different experimental designs and
studied different end-points. They have shown that severe
maternal hypothyroidism, induced by surgical thyroidec-
tomy or MMI treatment starting 2 wk before mating, alters
the expression of different cerebral genes at gestation d 16
(equivalent to our E15), and that their expression responds
within hours to single injections of T4 into the dam. These
observations increase the likelihood that the alterations in
neuronal migration and cytoarchitecture described here are
the consequence of inadequate and/or untimely expression
of one or more cerebral genes that are thyroid hormone
sensitive during this developmental period (31). The unique
features of the present model might be quite useful for the
identification of genes specifically involved in the radial mi-
gration of neurons into the cortex, which are involved in
processes such as neuron-glia and neuron-substrate adhe-
sion or signal molecules that might guide juvenile neurons
to their final destination (32).
The present study presents additional information with
respect to the study of iodine-deficient pups (11) regarding
the possible effects of this early maternal hypothyroxinemia
on radial migration of neurons generated in the cortical ven-
tricular zone vs. the tangential and radial migration of cells
originated in the medial ganglionic eminence and their final
radial positioning (4–6). These two populations of migrating
2 This lack of an increase in circulating TSH is in conceptual agree-
ment with previous observations (26) showing that in pregnant rats an
increase in circulating TSH is both delayed with respect to a decrease in
T4 and T3 and less marked than expected.
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neurons will give rise to glutamatergic (excitatory) and to
GABAergic (inhibitory) neurons, respectively. Present re-
sults confirm alteration in the radial migration of the former,
and exclude that of the latter, because the radial distribution
of cells ir to parvalbumin, calbindin D-28K, calretinin, and
nNOS was not affected in 3dMMI12 pups. This, however,
does not exclude the possibility that the tangential migration
of GABAergic neurons might also be abnormal in 3dMMI12
pups, despite their normal radial distribution.
Another important issue has been clarified with the
present experimental design, which could not be adequately
answered in iodine-deficient pups (11). The abnormal dis-
tribution of cells incorporating BrdU at E17–E19, as well as
the cytoarchitectural alterations described here, are the result
of the previous transient exposure to MMI. It would appear
that, once the initial radial neuronal migration is altered,
other phases of neurodevelopment might also be affected.
Functional and behavioral alterations
The abnormalities in cell migration and the subtle changes
in cytoarchitectonic organization found in the progeny of
3dMMI-treated dams indicate that the normal process
of brain maturation and, consequently, the establishment of
normal brain functions, are likely to be impaired. Indeed,
progeny of severely hypothyroid mothers, caused by chronic
MMI treatment, with altered neuronal migration and de-
ranged barrel formation, present alterations of GABAergic
(33), callosal (15, 34) and thalamo-cortical connections (20). In
addition, alterations of behavior and biogenic amine metab-
olism have been also observed in euthyroid pups of hypo-
thyroid pregnant rats (35). The increased audiogenic seizure
susceptibility reported here for the 3dMMI12 pups supports
the possibility that inhibitory circuits are altered. In the
3dMMI12 pups, about 20% of glutamatergic neurons are in
abnormal locations, as shown by their concomitant BrdU
labeling. Therefore, although the radial distribution of
GABAergic neurons is similar between normal and 3dMMI12
pups, many of these heterotopic neurons, mostly located in
layers Vb and VI are most probably abnormally innervated
by GABAergic axons because in these layers we have not
observed perisomatic parvalbumin-ir basquet terminals,
similar to those found in layers II–III and Va.
We tried the present crude behavioral test because we had
applied it before to the progeny of iodine-deficient dams (14),
following the procedure initially described for such animals
by van Middlesworth (24) and later applied to the progeny
of goitrogen-treated dams (25). Such studies disclosed a re-
lationship between audiogenic seizure susceptibility, hear-
ing loss and a derangement in the development of the organ
of Corti. The latter was known to be a postnatal event in
rodents and treatment of the dams with goitrogens was usu-
ally started from a few days before birth up to P14–P21 (25).
Such observations, therefore, did not suggest that early ma-
ternal hypothyroxinemia might also result in similar behav-
ioral defects. But it was also known that expression of the 1
and 2 thyroid hormone receptors (TR) transcripts appear
very early in the auditory system, at E12.5, and are restricted
to that portion of the inner ear that gives rise to the cochlea
(36). The later finding of audiogenic seizure susceptibility
and hearing loss in 1 and 2 TR-deficient mice (37)
prompted us to test the possible influence of maternal hy-
pothyroxinemia, at about E12, on the audiogenic responses
of their pups. They were indeed found to be abnormal in
many of the pups. We wish to remark, however, that this
finding might not be reproduced in rat strains that are ge-
netically resistant to audiogenic seizure susceptibility or less
susceptible to audiogenic seizure (38) than ours (14).
Epilepsy is a multifactorial disease in which not only cen-
tral and peripheral circuitry seems to be involved but also the
alteration of glutamatergic (excitatory) and GABAergic (in-
hibitory) cortical neuronal systems (39). In fact, selective
alterations in GABAA receptor subtypes in human temporal
lobe epilepsy have been recently reported (40). However,
these comments do not necessarily imply that the behavioral
alterations observed in 3dMMI12 and 3dMMI12  T4–15 are
causally related to the abnormal radial migration of neurons:
differences in the effects of T4 infusion on behavior compared
with those on corticogenesis suggest different underlying
mechanisms.
Possible clinical implications for adequate
human development
In humans, neurogenesis in the neocortex begins by
E35–E42 and ends by E140, whereas neural radial migra-
tion begins by E56 and ends by E168 (1, 2). Thus, neuro-
genesis and migration takes place in a total of about 125 d,
from wk 5– 6 to wk 24 after conception. In the rat, the same
events occur in about 10 d, between E11 and E21 (3).
Therefore, a period of time of 3 d in rats might correspond
roughly to a period of 37–38 d in humans. Extending these
speculations somewhat further, the present critical period
of sensitivity to maternal hypothyroxinemia would cor-
respond roughly from late first trimester of pregnancy up
to midgestation. Thus, our results strongly suggest that
abnormal neuronal migrations could be found in the prog-
eny of pregnant mothers that have been transiently and
moderately hypothyroxinemic/hypothyroid at the begin-
ning of fetal neocorticogenesis, even if only during as short
a period of time as 5– 6 wk. This hypothesis cannot be
assessed for ethical reasons, but a deficit of T4 for the fetus
during such a period of time may alter normal migration
of cortical neurons and the cytoarchitectonic organization
of the neocortex and hippocampus. These alterations
would become irreversible if T4 treatment were delayed.
The subtle changes in migration and cytoarchitecture de-
scribed here may be an underlying cause of the decreased
mental development and neurological alterations de-
scribed in children born in areas of mild and moderate ID
(9, 41) or in children born from mothers whose hypothy-
roxinemia early in pregnancy might be due to other causes
(7, 42– 44). Vermiglio et al. (45) have recently reported the
results of a more than 10 yr follow-up of 16 children,
euthyroid since birth, born to European mildly iodine-
deficient mothers, compared with 11 age- and sex-paired
children born to iodine-sufficient women from a nearby
control village. Thyroid function of the women had been
assessed clinically and biochemically at three time points
during gestation, with the mean FT4 of the iodine-deficient
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group being significantly lower than that of the controls at
8 wk (13.9 2.0 vs. 15.7 1.7 pmol/liter) and 13 wk (13.0
1.7 vs. 14.7 1.7 pmol/liter), whereas T3 and TSH were not
different. There was a difference of 18.1 points in the mean
IQ, in favor of the controls, with a correlation between
maternal FT4 before midgestation and the IQ of the off-
spring. Moreover, almost 70% (11/16) of the children born
to the moderately iodine-deficient mothers, and none of
the children of the control group, had attention deficit
hyperactivity disorders. This abnormally high frequency
of attention deficit hyperactivity disorders is surprisingly
similar to that reported for the syndrome of generalized
resistance to thyroid hormone, which is frequently the
consequence of mutations in 1 and 2 TR isoforms (46,
47). In both conditions, the underlying cause of the dis-
order may well be an inadequate availability of receptor-
bound T3 during early brain development.
In conclusion
Present experimental results are the first to show that a
moderate and transient maternal hypothyroxinemia dur-
ing a period roughly corresponding in man from the end
of the second month up to midgestation, causes irrevers-
ible alterations of brain development. These findings
should contribute significantly to our awareness of the
increasing number of reports on the poorer mental devel-
opment of children born to mothers who have been hy-
pothyroxinemic before midgestation, often only moder-
ately so, especially if this occurs at the beginning of cortical
neurogenesis and no palliative T4 therapy is applied to
prevent the possible damage. As pointed out by Utiger
(48), until 5 yr ago there was a general consensus that
thyroid hormone was necessary for adequate brain devel-
opment already during the third trimester of pregnancy,
but its role until the middle trimester was not generally
recognized. Attention was drawn, however, to the possible
damage caused by maternal thyroid hormone insuffi-
ciency during early development, especially because en-
vironmental conditions, such as ID, were increasingly de-
tected in women of child-bearing age, even in the United
States. Present experimental results fully support that thy-
roid hormone of maternal origin is necessary in adequate
amounts for normal brain development before and during
the middle trimester.
A condition of transient maternal hypothyroxinemia is
not likely to be detected early in pregnancy because it may
not result in clinical or even subclinical hypothyroidism.
T4 treatment of the latter condition is being strongly rec-
ommended (49) because the increased TSH indicates that
thyroidal hormone production is already inadequate for
that person, even if circulating concentration are within
the very broad normal range. Present results suggest that
this recommendation ought to be extended to maternal
hypothyroxinemia because production of T4 may already
be inadequate, although not sufficient to trigger an in-
crease in circulating TSH, physiologically suppressed dur-
ing the first trimester of pregnancy (8). This condition
appears to be quite frequent, even in Western societies
and, as shown here, is potentially damaging to the devel-
oping brain. For this reason, our present study strongly
supports our previous conclusions (7, 11, 50) regarding the
need to implement mass screening of pregnant women
early in gestation, at the beginning of neocortical neuro-
genesis. For the sake of the unborn child, these programs
should be based primarily on first trimester parameters
related to circulating FT4, and not only on the detection of
antithyroid Ab positivity and increased serum TSH, as
previously proposed for the sake of the mother (51).
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